Genflow Biosciences PLC Announces AGM Notice
-
Austria's Eurovision winner wants 2026 edition 'without Israel'
-
Stock markets fall as Trump tax cuts clear House
-
Courting controversy, Irish rap trio Kneecap face legal action
-
Dutch FM says supports "as free as possible" international trade
-
Paul Mescal says new gay romance film no 'Brokeback Mountain'
-
France detains 55 men in paedophile ring crackdown
-
Alcaraz gets Nishikori in Roland Garros opener as Sinner faces Frenchman
-
Vatican's diplomatic arm eyes return to fore with Ukraine talks
-
Els and Goosen: Golfers dragged into Trump's ambush of S.Africa leader
-
Merz warns of Russia threat, vows to defend NATO allies on Lithuania visit
-
UK court gives govt green light to reach Chagos Islands deal
-
England openers share unbeaten century stand in lone Zimbabwe Test
-
UK net migration in 2024 fell by half to 431,000
-
Norway parts ways with three ski jumping officials amid cheating probe
-
Arteta accepts Arsenal need 'firepower' in the transfer market
-
Zhang Weili keen to wow home crowd at first mainland post-Covid UFC event
-
Romanian court rejects far-right candidate's election appeal
-
Israel issues evacuation warning for parts of Gaza
-
EU parliament backs Russian fertiliser tax opposed by farmers
-
UK court reviews Chagos Islands deal after last-minute legal block
-
Stocks, oil prices retreat on US debt worries
-
Spain probes organised crime link in murder of ex-Ukraine MP
-
Jewish museum shooting suspect mistaken for victim: witnesses
-
Merz warns of Russia threat in visit to NATO's eastern flank
-
Garnacho unsure of Man Utd future after Europa League final snub
-
EU ready to tax Russian fertilisers from July
-
Zimbabwe bowl against England in one-off Test
-
Irish rappers Kneecap deny Hezbollah support after terror charge
-
'Hurt': Leningrad Siege survivor, 84, charged over peace placard
-
Rudiger and Musiala absent but Ter Stegen returns for Germany Nations League
-
Japan shows off futuristic 'railgun' at defence expo
-
Sifting through the rubble of Pakistan-India conflict
-
Norway film starring Elle Fanning gets 19-minute Cannes ovation
-
UK court orders last-minute review of Chagos Islands deal
-
Fernandes offers to leave Man Utd to help club rebuild
-
Stocks track Wall St sell-off as US deficit fears grow
-
'Serious' accident at North Korea warship launch: state media
-
Massive floods strand over 50,000 in eastern Australia
-
Deminers comb Belgian countryside for remnants of Great War
-
Somalia climate shocks and aid cuts create perfect storm
-
Ads pressured to evolve as AI changes Google search
-
Merz to visit Lithuania as Germany helps bolster NATO's eastern flank
-
Two Israeli embassy staff shot dead outside Jewish museum in Washington
-
Two Israeli staff shot dead outside Jewish museum in Washington
-
India's mother tongue teaching spells reading success
-
German far-right voters don't deserve empathy, says director Akin
-
EU ready to tax Russian fertilisers as early as July
-
Pacers roar back to stun Knicks in Eastern Conference finals opener
-
'Our legend': Australia football hails Europa-winning Postecoglou
-
Trier weaves his Cannes magic again with family affair
NYSE - LSE
| RYCEF | -0.09% | 10.91 | $ | |
| GSK | -0.18% | 38.47 | $ | |
| RIO | -0.95% | 61.398 | $ | |
| CMSC | -0.07% | 22.034 | $ | |
| AZN | -0.06% | 69.64 | $ | |
| BP | -1.23% | 28.529 | $ | |
| NGG | -1.36% | 72.58 | $ | |
| VOD | 0.33% | 10.455 | $ | |
| SCS | -0.1% | 10 | $ | |
| BTI | -0.65% | 44.175 | $ | |
| RBGPF | 6.25% | 67.2 | $ | |
| BCC | -0.2% | 87.16 | $ | |
| RELX | -0.97% | 54.57 | $ | |
| JRI | -0.95% | 12.6 | $ | |
| BCE | -0.49% | 21.365 | $ | |
| CMSD | -0.14% | 21.76 | $ |
Genflow Biosciences PLC Announces AGM Notice
LONDON, UNITED KINGDOM / ACCESS Newswire / May 22, 2025 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company") an emerging leader in the field of longevity research, focused on developing therapeutic solutions for the prevention of age-related diseases is pleased to announce that it will hold its Annual General Meeting ("AGM") at 9am on Thursday 12 June 2025 at One Heddon Street, London, W1B 4BD.
The Notice of the AGM ("Notice") and 2025 Form of Proxy will shortly be available on the Company's website, www.genflowbio.com, and was, where applicable, posted to shareholders on 19 May 2025. Further details of the arrangements for this year's AGM are set out in the Notice.
As announced on 30 April 2025, the Company's Annual Report and Accounts for the year ended 31 December 2024 are also available on the website and has, where applicable, also been posted to registered shareholders.
Contacts
Genflow Biosciences | Harbor Access |
Dr Eric Leire, CEO | Jonathan Paterson, Investor Relations |
+32-477-495-881 | +1 475 477 9401 |
Brokers | |
Capital Plus Partners Ltd | |
Dominic Berger, +44 203 821 6167 | |
Jon Critchley, +44 0203 821 6168 |
About Genflow Biosciences
Founded in 2020, Genflow Biosciences Plc. (LSE:GENF) (OTCQB:GENFF), a biotechnology company headquartered in the UK with R&D facilities in Belgium, is pioneering gene therapies to decelerate the aging process, with the goal of promoting longer and healthier lives while mitigating the financial, emotional, and social impacts of a fast-growing aging global population. Genflow's lead compound, GF-1002, works through the delivery of a centenarian variant of the SIRT6 gene which has yielded promising preclinical results. Scheduled to begin in 2025, Genflow's clinical trial aims to explore the potential benefits of GF-1002 in treating MASH (Metabolic Dysfunction-Associated Steatohepatitis), the most prevalent chronic liver disease for which there is no effective treatments. Please visit www.genflowbio.com and follow the Company on LinkedIn and Twitter/X.
-Ends-
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
SOURCE: Genflow Biosciences PLC
View the original press release on ACCESS Newswire
O.Karlsson--AMWN